Compositions and methods to improve rna properties using base, phosphodiester linkage, sugar backbone, and cap modifications
AssigneesThe Broad Institute, Inc., Massachusetts Institute of Technology
InventorsXiao Wang, Hongyu Chen, Dangliang Liu
Life of this patent
Estimating the term…
Abstract
Disclosed herein are capped RNA transcripts comprising one or more modified nucleotides at position +3 or higher with reference to a 5′ terminus of the RNA molecule, and methods of making the same. Also provided are compositions comprising one or more of the capped RNA transcripts provided herein, and methods of using said compositions for therapeutic applications.
Claims36
A method of producing a composition of capped RNA transcripts, comprising:
- (a) synthesizing a 5′-phosphorylated RNA oligonucleotide in a solvent system comprising a nonpolar counterion;
- (b) capping the 5′-phosphorylated RNA oligonucleotide, thereby producing a capped RNA oligonucleotide;
- (c) purifying the capped RNA oligonucleotide, thereby producing a composition comprising a purified capped RNA oligonucleotide, wherein at least 95% of the total RNA oligonucleotides in the composition are capped RNA oligonucleotides;
- and
- (d) ligating the purified capped RNA oligonucleotide to an RNA precursor, thereby producing a capped RNA transcript.
-5. (canceled)
-11. (canceled)
-15. (canceled)
(canceled)
-24. (canceled)
-46. (canceled)
-66. (canceled)
-71. (canceled)
-78. (canceled)
-84. (canceled)
A method of screening for altered translation efficiency or RNA stability conferred by one or more nucleotide modifications in an RNA transcript, comprising:
- (a) synthesizing a 5′-phosphorylated RNA oligonucleotide comprising one or more modified nucleotides in a solvent system comprising a nonpolar counterion;
- (b) chemically capping the 5′-phosphorylated RNA oligonucleotide, thereby producing a capped RNA oligonucleotide;
- (c) purifying the capped RNA oligonucleotide;
- (d) ligating the capped RNA oligonucleotide to an RNA precursor comprising an open reading frame (ORF) encoding a protein, thereby producing a capped RNA transcript;
- (e) expressing the capped RNA transcript in a cell;
- and
- (f) measuring expression of the protein in the cell.
-166. (canceled)
An RNA molecule comprising (i) one or more modified nucleotides at position +3 or higher with reference to a 5′ terminus of the RNA molecule, and (ii) at least one 5′ cap.
-200. (canceled)
-208. (canceled)
-213. (canceled)
-220. (canceled)
-224. (canceled)
A kit comprising the composition of claim 220, a device for administering the composition to a subject, and/or instructions for administering the composition to the subject.
Dependencies are inferred from the claim text.